Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey
- PMID: 3399296
Live virus vaccines in human immunodeficiency virus-infected children: a retrospective survey
Abstract
Live virus vaccines can cause serious adverse reactions when administered to immunocompromised patients. Because children infected with human immunodeficiency virus (HIV) may be immunosuppressed, immunization of these children with live virus vaccines is a potential problem. A retrospective survey was conducted by the New York City Department of Health, with consultation from the Centers for Disease Control, to evaluate the frequency of serious adverse events following receipt of live vaccines among children with HIV infection receiving pediatric care in New York City and New Jersey. Outpatient records of 319 children being cared for by 16 participating physicians were reviewed. Of the 319 charts, 221 (69%) contained vaccination histories. Perinatal transmission of HIV infection was suspected for 208 (94%) of the 221 cases and infection via transfusion for the remaining 13 (6%). Of the 221 for whom immunization histories were available, 180 (81%) had received at least one dose of live oral polio vaccine and 70 (32%) had received measles, mumps, and rubella vaccine. There were 120 children for whom a temporal relationship between immunization and onset of symptoms of immunodeficiency could be seen; 46/120 had received at least one dose of oral polio vaccine and 23/45 had received measles, mumps, and rubella vaccine after onset of symptoms. Although follow-up of this population has been limited, there were no reports of serious adverse events such as typical or atypical measles, paralytic poliomyelitis, or aseptic meningitis in the month following vaccination.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Measles pneumonitis following measles-mumps-rubella vaccination of a patient with HIV infection, 1993.MMWR Morb Mortal Wkly Rep. 1996 Jul 19;45(28):603-6. MMWR Morb Mortal Wkly Rep. 1996. PMID: 8676852
-
Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.Dev Biol Stand. 1986;65:25-7. Dev Biol Stand. 1986. PMID: 3549399 Clinical Trial.
-
Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.Biken J. 1986 Dec;29(3-4):63-71. Biken J. 1986. PMID: 3304276
-
Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.Vaccine. 2008 Feb 26;26(9):1166-72. doi: 10.1016/j.vaccine.2007.12.049. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255204 Review.
-
Safe administration of the measles vaccine to children allergic to eggs.N Engl J Med. 1995 May 11;332(19):1262-6. doi: 10.1056/NEJM199505113321904. N Engl J Med. 1995. PMID: 7708070 Review.
Cited by
-
Preventing secondary infections among HIV-positive persons.Public Health Rep. 1991 Sep-Oct;106(5):503-17. Public Health Rep. 1991. PMID: 1910184 Free PMC article.
-
Vaccination in HIV-infected Patients.Curr Infect Dis Rep. 2000 Jun;2(3):245-256. doi: 10.1007/s11908-000-0042-8. Curr Infect Dis Rep. 2000. PMID: 11095863
-
Active immunization in the United States: developments over the past decade.Clin Microbiol Rev. 2001 Oct;14(4):872-908, table of contents. doi: 10.1128/CMR.14.4.872-908.2001. Clin Microbiol Rev. 2001. PMID: 11585789 Free PMC article. Review.
-
Paralytic poliomyelitis associated with live oral poliomyelitis vaccine in child with HIV infection in Zimbabwe: case report.BMJ. 1999 Mar 27;318(7187):841-3. doi: 10.1136/bmj.318.7187.841. BMJ. 1999. PMID: 10092261 Free PMC article.
-
Immunization of HIV infected children.Indian J Pediatr. 2012 Dec;79(12):1634-41. doi: 10.1007/s12098-012-0701-4. Epub 2012 Feb 10. Indian J Pediatr. 2012. PMID: 22323103 Review.
MeSH terms
Substances
LinkOut - more resources
Medical